Holen Sie sich die Stockscreener-App
13.77
3.53%
0.47
Handel nachbörslich:
13.77
Schlusskurs vom Vortag:
$13.30
Offen:
$13.49
24-Stunden-Volumen:
50,047
Relative Volume:
0.18
Marktkapitalisierung:
$254.68M
Einnahmen:
$62.81M
Nettoeinkommen (Verlust:
$-13.75M
KGV:
-17.21
EPS:
-0.8
Netto-Cashflow:
$153.00K
1W Leistung:
-2.82%
1M Leistung:
+6.09%
6M Leistung:
+155.00%
1J Leistung:
+35.00%
1-Tages-Spanne:
$13.49
$13.84
1-Wochen-Bereich:
$12.71
$14.96
52-Wochen-Spanne:
$3.78
$15.71
Optimizerx Corp Stock (OPRX) Company Profile
Firmenname
Optimizerx Corp
Sektor
Branche
Telefon
248-651-6558
Adresse
260 CHARLES STREET, WALTHAM, MI
Vergleichen Sie OPRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
13.77 | 245.98M | 62.81M | -13.75M | 153.00K | -0.80 |
|
VEEV
Veeva Systems Inc
|
286.01 | 46.61B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
64.86 | 10.57B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
96.91 | 8.42B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
61.00 | 11.13B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
36.96 | 6.33B | 906.14M | -52.62M | 89.62M | -0.3621 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-08 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
| 2024-07-25 | Fortgesetzt | B. Riley Securities | Buy |
| 2024-04-04 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2023-02-02 | Fortgesetzt | B. Riley Securities | Buy |
| 2022-11-01 | Eingeleitet | Stifel | Buy |
| 2022-07-15 | Eingeleitet | SVB Leerink | Outperform |
| 2021-10-18 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-04-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2019-01-03 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Optimizerx Corp Aktie (OPRX) Neueste Nachrichten
How OptimizeRx Corporation stock performs during market volatilityStrong Buy Recommendations - Newser
Best Growth Stocks to Buy for July 22nd - TradingView
OptimizeRx Corporation Stock Analysis and ForecastFree High-Return Strategy Alerts - jammulinksnews.com
OptimizeRx Corp. (NASDAQ:OPRX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
What makes OptimizeRx Corporation stock price move sharplyProven High Yield Signals - Newser
OPRX vs. GDRX: Which Health Tech Stock Has Stronger Revenue Momentum? - MSN
OptimizeRx: Stock Could Rise As Profitability Is Achieved - Seeking Alpha
Can OPRX's Patient Engagement Tools Win Amid Fierce Competition? - The Globe and Mail
OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET - The Globe and Mail
OptimizeRx Corp. to Host Conference Call for Q2 2025 Financial Results on August 7, 2025 - Quiver Quantitative
Capstone Lands Major Clean Energy Win: 90% Government-Funded Microturbine Project Shows Long-Term Success - Stock Titan
OPRX Vs. GDRX: Which Health Tech Stock Has Stronger Revenue Momentum? - Barchart.com
Why OptimizeRx Corporation stock attracts strong analyst attentionFree Risk Assessment Services - Newser
Calamos Advisors LLC Invests $289,000 in OptimizeRx Corp. (NASDAQ:OPRX) - MarketBeat
OptimizeRx Bets on AI and Workflow Integration: Will This Pay Off? - sharewise.com
Best Growth Stocks To Buy For July 9th - Barchart.com
Best Growth Stocks to Buy for July 9th - The Globe and Mail
Can OptimizeRx Maintain Profit Growth Amid Evolving Pharma Spend? - Zacks Investment Research
OPRX Shares Rise 69.3% in 3 Months: Time to Bet on the Stock? - sharewise.com
Janney Montgomery Scott LLC Purchases 39,969 Shares of OptimizeRx Corp. (NASDAQ:OPRX) - MarketBeat
OptimizeRx Corp. (NASDAQ:OPRX) Position Boosted by Janney Montgomery Scott LLC - Defense World
3,845 Shares in OptimizeRx Corp. (NASDAQ:OPRX) Bought by GAMMA Investing LLC - Defense World
Best Growth Stocks to Buy for June 25th - Yahoo Home
OptimizeRx appoints CEO Steve Silvestro to board of directors - Investing.com India
OptimizeRx Corp. Appoints Steve Silvestro to its Board of Directors, Effective as of June 20, 2025 - MarketScreener
Simulmedia and OptimizeRx Announce Partnership from the Cannes Lions - Business Wire
Calculating The Fair Value Of OptimizeRx Corporation (NASDAQ:OPRX) - Yahoo Finance
OptimizeRx Co. (NASDAQ:OPRX) Shares Bought by Bank of America Corp DE - MarketBeat
OptimizeRx Co. (NASDAQ:OPRX) Shares Purchased by Bank of America Corp DE - Defense World
OptimizeRx (NASDAQ:OPRX) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says - MarketBeat
Kalkine : indexnasdaq ixic OptimizeRx Drives Healthcare Tech Communication Shift - Kalkine Media
OptimizeRx (NASDAQ:OPRX) Given New $16.00 Price Target at Stifel Nicolaus - Defense World
OptimizeRx (OPRX) Price Target Raised by Stifel Analyst | OPRX S - GuruFocus
OptimizeRx (OPRX) Price Target Raised by Stifel to $16 | OPRX St - GuruFocus
Stifel raises OptimizeRX stock price target to $16 from $12 By Investing.com - Investing.com South Africa
Stifel raises OptimizeRX stock price target to $16 from $12 - Investing.com
OptimizeRx Co. (NASDAQ:OPRX) Shares Bought by Squarepoint Ops LLC - Defense World
Here's Why OptimizeRx Corp. (OPRX) is a Great Momentum Stock to Buy - sharewise
OptimizeRx Corp (OPRX) Stock Price Up 6.89% on Jun 5 - GuruFocus
New Strong Buy Stocks for June 4th - TradingView
Finanzdaten der Optimizerx Corp-Aktie (OPRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Optimizerx Corp-Aktie (OPRX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Silvestro Stephen L | Chief Commercial Officer |
Mar 01 '25 |
Option Exercise |
0.00 |
1,928 |
0 |
121,886 |
| Odence-Ford Marion | Chief Legal Officer & CHRO |
Mar 01 '25 |
Option Exercise |
0.00 |
771 |
0 |
70,544 |
| KLEMA CATHY | Director |
Feb 02 '25 |
Option Exercise |
0.00 |
5,109 |
0 |
11,752 |
| Odence-Ford Marion | General Counsel and CCO |
Dec 19 '24 |
Option Exercise |
0.00 |
3,927 |
0 |
28,383 |
| Silvestro Stephen L | Chief Commercial Officer |
Dec 19 '24 |
Option Exercise |
0.00 |
6,546 |
0 |
83,424 |
| Besch Doug | Chief Product Officer |
Dec 19 '24 |
Option Exercise |
0.00 |
1,964 |
0 |
12,160 |
| Stelmakh Edward | CFO/COO |
Dec 19 '24 |
Option Exercise |
0.00 |
5,237 |
0 |
38,603 |
| FEBBO WILLIAM J | CEO |
Dec 12 '24 |
Buy |
5.01 |
20,000 |
100,220 |
601,253 |
| Odence-Ford Marion | General Counsel and CCO |
Nov 08 '24 |
Option Exercise |
0.00 |
1,785 |
0 |
24,980 |
| Stelmakh Edward | CFO/COO |
Oct 11 '24 |
Option Exercise |
0.00 |
8,222 |
0 |
35,432 |
1.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):